U.S. FDA approves Astellas drug for invasive fungal infections
March 06, 2015 at 14:24 PM EST
March 6 (Reuters) - U.S. health regulators on Friday approved Japanese drugmaker Astellas Pharma Inc's drug for the treatment of two rare, often fatal invasive fungal infections that target patients with blood cancers.
